Alterola Biotech Inc
OTC:ABTI
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Aegis Vopak Terminals Ltd
NSE:AEGISVOPAK
|
IN |
Alterola Biotech Inc
Capital Expenditures
Alterola Biotech Inc
Capital Expenditures Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Capital Expenditures | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
Alterola Biotech Inc
OTC:ABTI
|
Capital Expenditures
$0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Estee Lauder Companies Inc
NYSE:EL
|
Capital Expenditures
-$533m
|
CAGR 3-Years
19%
|
CAGR 5-Years
2%
|
CAGR 10-Years
0%
|
|
|
Bellring Brands Inc
NYSE:BRBR
|
Capital Expenditures
-$7.6m
|
CAGR 3-Years
-72%
|
CAGR 5-Years
-40%
|
CAGR 10-Years
N/A
|
|
|
Coty Inc
NYSE:COTY
|
Capital Expenditures
-$215m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Inter Parfums Inc
NASDAQ:IPAR
|
Capital Expenditures
-$48.2m
|
CAGR 3-Years
29%
|
CAGR 5-Years
-31%
|
CAGR 10-Years
9%
|
|
|
elf Beauty Inc
NYSE:ELF
|
Capital Expenditures
-$31.6m
|
CAGR 3-Years
-157%
|
CAGR 5-Years
-38%
|
CAGR 10-Years
-12%
|
|
Alterola Biotech Inc
Glance View
Alterola Biotech, Inc. develops medical cannabis products. The company is headquartered in Walnut, California. The company went IPO on 2010-03-09. The firm is focused on developing pharmaceutical medicines made from cannabinoid, cannabinoid-like and non-cannabinoid active pharmaceutical ingredients (APIs) globally. The company is also focused on developing non-pharmaceutical (nutraceutical / dietary supplement) products containing cannabinoids, cannabinoid-like and non-cannabinoid food-grade ingredients. In addition, the Company is focused on supplying cosmetic ingredients to potential customers who develops products containing cannabinoids, cannabinoid-like and non-cannabinoid ingredients.
See Also
What is Alterola Biotech Inc's Capital Expenditures?
Capital Expenditures
0
USD
Based on the financial report for Jun 30, 2024, Alterola Biotech Inc's Capital Expenditures amounts to 0 USD.